The Lancet Neurology: July 14, 2008

07/14/08 • 8 min

The Lancet Neurology in conversation with

Helen Frankish discusses biomarkers for indications of dementia, and other highlights from the August issue.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Helen Frankish discusses biomarkers for indications of dementia, and other highlights from the August issue.

Previous Episode

The Lancet Neurology: June 16, 2008

The International LRRK2 Consortium, which includes investigators in 21 centres, has collected data from almost 20000 patients with Parkinson's disease carrying mutations in the LRRK2 gene. The Lancet Neurology editor Elena Becker-Barroso and Daniel Healy, the corresponding author on their first report, summarises the findings and their implications in clinical practice in a podcast.

Next Episode

The Lancet Neurology: August 11, 2008

Elena Becker-Barroso discusses highlights from the September issue, including the potential of PB2 to slow the development of amyloid beta in patients with Alzheimer's, and how telemedicine could improve stroke treatment.